Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers  by MacIntyre, C. Raina et al.
Preventive Medicine 62 (2014) 1–7
Contents lists available at ScienceDirect
Preventive Medicine
j ourna l homepage: www.e lsev ie r .com/ locate /ypmedEfﬁcacy of face masks and respirators in preventing upper respiratory
tract bacterial colonization and co-infection in hospital
healthcare workersC. Raina MacIntyre a,b, Quanyi Wang c, Bayzidur Rahman a, Holly Seale a, Iman Ridda a,b, Zhanhai Gao a,
Peng Yang c, Weixian Shi c, Xinghuo Pang c, Yi Zhang c, Aye Moa a,⁎, Dominic E. Dwyer d
a School of Public Health and Community Medicine, UNSW Medicine, University of New South Wales, Australia
b National Centre for Immunization Research and Surveillance, The Children's Hospital at Westmead, Sydney, Australia
c The Beijing Center for Disease Prevention and Control, Beijing, China
d Centre for Infectious Diseases and Microbiology Laboratory Services, Institute for Clinical Pathology and Medical Research, Westmead Hospital and University of Sydney, Australia⁎ Corresponding author at: School of Public Health an
Medicine, University of New South Wales, Gate 11, Botan
Australia.
E-mail address: a.moa@unsw.edu.au (A. Moa).
http://dx.doi.org/10.1016/j.ypmed.2014.01.015
0091-7435/© 2014 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oAvailable online 25 January 2014Keywords:
N95 respirators and medical masks
Healthcare workers
Hospitals
Bacterial colonization
Objective.We compared the efﬁcacy of medical masks (MM) and N95 respirators (N95) in preventing bacte-
rial colonization/infection in healthcare workers (HCWs).
Methods. A cluster randomized clinical trial (RCT) of 1441 hospital HCWs randomized to medical masks or
N95 respirators, and compared to 481 control HCWs, was performed in Beijing, China, during the winter season
of 2008–2009. Participants were followed for development of clinical respiratory illness (CRI). Symptomatic sub-
jects were tested for Streptococcus pneumoniae, Bordetella pertussis, Chlamydia pneumoniae, Mycoplasma
pneumoniae or Haemophilus inﬂuenza type B by multiplex polymerase chain reaction (PCR).
Results. The rate of bacterial colonization was 2.8% in the N95 group (p = 0.02), 5.3% among medical mask
users (p b 0.01) and 7.5% among the controls (p= 0.16). N95 respirators were signiﬁcantly protective (adjusted
RR 0.34, 95% CI: 0.21–0.56) against bacterial colonization. Co-infections of two bacteria or a virus and bacteria oc-
curred in up to 3.7% of HCWs, and were signiﬁcantly lower in the N95 arm.
Conclusions. N95 respirators were signiﬁcantly protective against bacterial colonization, co-colonization and
viral-bacterial co-infection.We showed that dual respiratory virus or bacterial-viral co-infections can be reduced
by the use of N95 respirators. This study has occupational health and safety implications for health workers.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
Healthcare workers (HCWs) are at a signiﬁcantly increased occupa-
tional risk for a range of infections. These include infections that cause
substantial illness and occasional deaths in HCWs (Decker and
Schaffner, 1996; Eriksen et al., 2005; Klevens et al., 2007), or are associ-
ated with healthcare associated infections (the majority of which are
caused by bacteria). Various infectious agents can be transmitted from
patients to HCWs and vice versa (Weber et al., 2010). As droplet trans-
mission is a major mode of transmission of some pathogens, standard
infection control measures like hand washing alonemay not be enough
to prevent HCW transmission or outbreaks. HCWs can transmit infec-
tions such as tuberculosis, varicella, and inﬂuenza by the airborne
route (Weber et al., 2010); it is less well appreciated that airborne and
other routes of transmission of certain bacterial pathogens may occur.d Community Medicine, UNSW
y Street, Randwick, NSW 2052,
. This is an open access article underThere is a low awareness of bacterial infections as an occupational
health risk for HCWs. In addition, antibiotic resistant bacteria are a
very signiﬁcant problem facing hospitals, and HCWs play a role in
their transmission. Bacterial respiratory tract infections are generally
not considered a major occupational problem for HCWs. A growing
body of evidence suggests that the risk of bacterial respiratory infections
is increased by co-infection with viruses and vice-versa, and this has
been studied mostly around the relationship between inﬂuenza and
pneumococcus (Klugman et al., 2009; Madhi and Klugman, 2004;
MMWR, 2009; Zhou et al., 2012). Bacterial load in the nasopharynx is
also thought to be related to risk of invasive disease or bacterial–viral
co-infection (Klugman et al., 2009). A meta-analysis showed frequent
bacterial co-infections during inﬂuenza outbreaks (Wang et al., 2011).
Streptococcus pneumoniae, Haemophilus inﬂuenzae, Staphylococcus spp.
and other Streptococcus spp. are the commoner causes of bacterial sec-
ondary infection following an inﬂuenza-like illness (ILI) (Wang et al.,
2011).
Case studies documenting the role of HCWs in transmission of
S. pneumoniae are absent, possibly because this is usually not an
outbreak-associated disease, and because the pathogenesis of invasivethe CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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Further, HCWs with invasive pneumococcal disease may go unreported
in the occupational context (Sherertz et al., 2001). On the other hand,
Bordetella pertussis outbreaks among HCWs have been widely reported
(Addiss et al., 1991; Gehanno et al., 1999; Pascual et al., 2006),with such
outbreaks attributed to airborne transmission through droplets
(Nouvellon et al., 1999). In another study, evidence of acute infection
with Chlamydia pneumoniae was detected in 2% of HCWs (Hyman
et al., 1995). Outbreaks ofMycoplasma pneumoniae among HCWs have
been observed in Finland, where 44% (n= 97) of HCWs tested positive
for the pathogen without detectableM. pneumoniae-speciﬁc antibody,
suggesting acute infection (Kleemola and Jokinen, 1992). Legionella
has also been described as an occupational risk factor for HCWs
(Borella et al., 2008; Rudbeck et al., 2009). In contrast to these out-
breaks, there are few prospective studies of bacterial respiratory infec-
tions or colonization and the clinical implications for HCWs.
There has been recent interest in the role of medical masks and res-
pirators in preventing respiratory infections in HCWs and the general
community (MacIntyre et al., 2009, 2011, 2013). Medical masks
(MMs) are unﬁtted devices worn by an infected person, HCW, or mem-
ber of the public to reduce transfer of potentially infectious body ﬂuids
between individuals. They were originally designed for surgeons in
order to attenuate wound contamination, but have not been demon-
strated to have their intended efﬁcacy (Mitchell and Hunt, 1991; Orr,
1981; Tunevall, 1991). Of note, MMs have not been shown to clearly
provide respiratory protection in the community or HCW setting
(Aiello et al., 2012; Cowling et al., 2009; MacIntyre et al., 2009, 2011).
This may be attributed to lower ﬁltration efﬁciency and poorer ﬁt than
respirators which, in contrast, are speciﬁcally designed to provide respi-
ratory protection (Balazy et al., 2006; Lawrence et al., 2006;Weber et al.,
1993).We have previously shown that a N95 respirator provides signif-
icantly better protection against clinical respiratory infection thanmed-
ical masks in HCWs (MacIntyre et al., 2011, 2013). Although our
previous work tested clinical efﬁcacy in preventing infection, the rela-
tive importance of different routes of transmission (airborne, aerosol,
and direct hand-to-mouth contact) in the clinical efﬁcacy of respiratory
protection is unknown. That is, a mask may provide protection against
more than one mode of transmission. The only bacterial infection for
which respirators are considered and recommended for HCWs is tuber-
culosis (Chen et al., 1994; Nicas, 1995). In this study, our aimwas to de-
termine the efﬁcacy of respiratory protection in preventing bacterial
colonization and co-infections or co-colonization in HCWs.
Methods
A prospective, cluster randomized trial of N95 respirators (ﬁt tested and
non-ﬁt tested) and medical masks compared to each other and to controls
who did not routinely wear masks was conducted in frontline HCWs during
the winter of 2008–2009 (December to January) in Beijing, China. The method-
ology and consort diagram used in the study and the primary clinical and viral
infection outcomes have been previously described (MacIntyre et al., 2011).
We also measured bacterial colonization/infection and co-infections in symp-
tomatic trial subjects, which has not been previously reported. This study de-
scribes the efﬁcacy of the interventions (N95 respirators and medical masks)
in preventing bacterial colonization and co-infection in HCWs.
Recruitment commenced on December 1, 2008 and ﬁnal follow-up com-
pleted on January 15, 2009. 1441 HCWs in 15 hospitals were randomized to
one of three intervention arms: (1)Medical masks (3M™medicalmask, catalog
number 1820); (2) N95 ﬁt tested mask (3M™ ﬂat-fold N95 respirator, catalog
number 9132); (3) N95 non-ﬁt testedmask (3M™ ﬂat-fold N95 respirator, cat-
alog number 9132) (MacIntyre et al., 2011). A secure computerized randomiza-
tion program was used to randomize the hospitals to each intervention. A
convenience control group of 481 HCW who did not routinely wear masks
were recruited and prospectively followed up in the same way as the trial par-
ticipants for the development of symptoms. The study protocol was approved
by the Institutional Review Board (IRB), Human Research Ethics Committee of
the Beijing Ministry for Health. Staff who agreed to participate provided in-
formed consent.The primary study endpoint was the presence of laboratory-conﬁrmed bac-
terial colonization of the respiratory tract in subjects who were symptomatic.
We tested for S. pneumoniae, Legionella spp., B. pertussis, Chlamydia,
M. pneumoniae or H. inﬂuenzae type B by multiplex PCR. These organisms have
been reported in the HCW setting (Kurt et al., 1972; Rudbeck et al., 2009;
Wang et al., 2011). We also looked at co-colonization with more than one bac-
teria, and co-infection with a laboratory-conﬁrmed viral infection and bacterial
colonization. Laboratory-conﬁrmed viral respiratory infection was deﬁned as
detection of adenoviruses, human metapneumovirus, coronaviruses 229E/
NL63 and OC43/HKU1, parainﬂuenza viruses 1, 2 and 3, inﬂuenza viruses A
and B, respiratory syncytial viruses A and B, or rhinovirus A/B by nucleic acid
testing (NAT) (MacIntyre et al., 2011).
Eligibility
Nurses or doctors who worked full time in the emergency or respiratory
wards at the participating hospitals were eligible. HCWs were excluded if
they: (1) were unable or refused to consent; (2) had beards, long mustaches
or long facial hair stubble; (3) had a current respiratory illness, rhinitis and/or
allergy; and (4)worked part-time or did notwork in the selectedwards/depart-
ments (MacIntyre et al., 2011).
Intervention
Subjects were randomized to masks or respirators, and wore the mask or
respirator on every shift (8–12 h) for four consecutive weeks and were shown
how to wear it and ﬁt it correctly. Participants were supplied daily with three
masks for the medical mask group or two N95 respirators. They were asked to
store the mask in a paper bag every time they removed it (for toilet breaks,
tea ⁄lunch breaks and at the end of every shift) and place the bagged mask or
respirator in their locker. All participants were instructed on the importance
of hand hygiene prior to⁄ after the removal of medical masks and respirators,
as described (MacIntyre et al., 2011). Participants in the ﬁtted N95 arm
underwent a ﬁt testing procedure using a 3M™ FT-30 Bitrex Fit Test Kit accord-
ing to the manufacturers' instructions (3M™, St Paul, MN, USA) (MacIntyre
et al., 2011).
Follow-up
All participantswere followedup for fourweeks for development of respira-
tory symptoms, and for an additional week after mask wearing had ceased (to
account for incubation of infections acquired in week 4). Validated diary cards
were provided for the four-week period to record daily the (1) number of
hours worked; (2) mask/respirator usage; and (3) recognized CRI (MacIntyre
et al., 2011).
Participants were contacted daily by the study team either by phone or face-
to-face contact to actively identify incident cases of viral respiratory infection.
CRI was deﬁned as at least two respiratory symptoms (cough, sneezing, runny
nose, shortness of breath, sore throat) or one respiratory symptom and one sys-
temic symptom (including fever, headache, and lethargy). If any respiratory
symptom was present, subjects were tested, following collection of a nose and
throat swab, for bacterial and viral pathogens.
Sample collection and laboratory testing
Subjectswith respiratory symptoms had two pharyngeal swabs collected by
a trained nurse or doctor. Double rayon-tipped, plastic-shafted swabswere used
to scratch both tonsil areas and the posterior pharyngeal wall. These were
transported immediately after collection to the laboratory, or at 4 °C if transport
was delayed within 48 h. Pharyngeal swabs were tested at the Laboratories of
the Beijing Centers for Disease Control and Prevention. Amultiplex PCR (Seegen
Inc., Seoul, Korea)was used to detect S. pneumoniae,M. pneumoniae, B. pertussis,
Legionella spp., Chlamydia and H. inﬂuenza type B. After preheating at 95 °C for
15 min, 40 ampliﬁcation cycles were carried out under the following condi-
tions in a thermal cycler (GeneAmp PCR system 9700, Foster City, CA, USA):
94 °C for 30 s, 60 °C for 1.5 min, and 72 °C for 1.5 min. Ampliﬁcation was com-
pleted at the ﬁnal extension step at 72 °C for 10 min. The multiplex PCR prod-
ucts were visualized by electrophoresis on an ethidium bromide-stained 2%
agarose gel. Laboratory-conﬁrmed viral respiratory infection, deﬁned as detec-
tion of adenoviruses, human metapneumovirus, coronaviruses 229E/NL63 and
OC43/HKU1, parainﬂuenza viruses 1, 2 and 3, inﬂuenza viruses A and B, respira-
tory syncytial viruses A and B, or rhinovirus A/B by nucleic acid testing (NAT)
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Seoul, Korea) as previously described (MacIntyre et al., 2011).Analysis
The endpoint of interest, bacterial colonization and co-infection with two
bacteria or virus and bacteria were analyzed by intention-to-treat analysis.
The two N95 arms (ﬁt-tested and non-ﬁt-tested) were combined for analysis,
given that there was no signiﬁcant difference between them and because
rates of ﬁt test failure were extremely low in the ﬁt tested arm (5⁄461 ﬁt test
failures — in other words, the majority of HCWs who underwent ﬁt-testing
were wearing the mask correctly prior to ﬁt testing, and ﬁt testing did not add
a signiﬁcant beneﬁt, allowing us to combine data from the ﬁt tested and non-
ﬁt tested arms) (MacIntyre et al., 2011). We calculated the relative risk and ef-
ﬁcacy of the N95 arms usingmedical mask group as the reference category, and
also the efﬁcacy of N95 and medical mask group using control as the reference
category.
We ﬁtted a multivariable log binomial model, using generalized estimating
equation (GEE) to account for clustering by hospital, to estimate relative risk
(RR) after adjusting for potential confounders. In the initial model, we included
all the variables along with the main exposure variable (randomization arm)
that were signiﬁcant (p b 0.25) in the univariable analysis. A backward elimina-
tion method was used to remove the variables that did not have any confound-
ing effect, that is, could not make meaningful change (±10%) in the RR of the
N95 arms (Kleinbaum et al., 2007, 2010; Vittinghoff et al., 2012). In the multi-
variable analysis we estimated RR for N95 and medical mask arms compared
to the control arm.Results
A total of 1441 nurses and doctors in 15hospitalswere recruited into
the intervention arms, and 481 nurses and doctors in 9 hospitals were
recruited into the control group (Fig. 1). The distribution of socio-Fig. 1. A consort diagram fdemographic variables was generally similar between arms, as previ-
ously reported (MacIntyre et al., 2011).
Fig. 2 illustrates the rates of bacterial detection in symptomatic
HCWs by trial arm, and shows increasing rates with decreasing level
of respiratory protection. Table 1 shows bacterial and viral infections,
as well as co-infections or co-colonization with multiple pathogens, in-
cluding co-infectionwith bacteria and virus. The rates of bacterial detec-
tion were lower for N95 respirators compared to MM (2.8% and 5.3%
respectively), and was highest (7.5%) among the controls. By intention
to treat analysis, N95 respirators were signiﬁcantly more protective
than MM against the laboratory-conﬁrmed presence of bacteria, with
an efﬁcacy of 46% against medical masks and 62% against control.
MMs had no signiﬁcant efﬁcacy against any outcome compared to con-
trol (Table 1).
Rates of all types of co-infection were signiﬁcantly lower in the N95
group. N95 (but notMM) demonstrated efﬁcacy againstmultiple bacte-
rial pathogen colonization as well as co-infection with a virus and bac-
teria, and against dual virus infection (Table 1). There were no dual
virus infections in controls (0/481), 2/949 in the N95 group and 5/492
in MM group. The MM arm had a higher rate of dual virus infection
than controls, but the difference between MM and control did not
reach statistical signiﬁcance. The most common bacteria identiﬁed
was S. pneumoniae; 2.5% for N95; 4.7% for MM, and 6.2% for control
arm, followed by H. inﬂuenzae type B; 2%, 3.7%, and 5% respectively
(data not shown). These differences were statistically signiﬁcant across
all three arms. B. pertussiswas also detected in three HCWs.
In a multivariable cluster adjusted log binomial model, when com-
pared to the control group, the N95 group was signiﬁcantly protective
against bacterial colonization (Table 2). We demonstrated 59% efﬁcacy
of N95 respirators against any co-infection (Table 3), and 67% against
bacterial and viral co-infection (Table 4) in adjusted multivariate analy-
ses. The only other signiﬁcant variable for bacterial infection andor the study selection.
Fig. 2. Bacterial colonization by trial arm.1.
Table 2
Multivariable cluster adjusted log binomial model of bacterial infection compared
with control group.
Variables in the model Relative risk (95% CI)
N95 0.34 (0.21–0.56)a,†
Medical mask 0.67 (0.38–1.18)
Hospital level 1.48 (0.91–2.42)
High-risk procedure 1.34 (0.84–2.13)
Inﬂuenza vaccine 1.03 (0.58–1.83)
Hand washing 0.82 (0.47–1.43)
Respiratory ward vs other 2.15 (1.39–3.31)†
a Efﬁcacy 66%.
† Signiﬁcant p values (p b 0.01).
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cantly increased the risk of colonization or co-infection compared to
other wards (Tables 2 and 4).
In addition, univariable analyses of infection and co-infection rates
by other factors, such as, smoking (current vs non-smoker), staff type
(doctor vs nurses) andward type (respiratory vs other)were conducted
in the analysis. For bacterial infection, HCWs working in a respiratory
ward were signiﬁcantly at higher risk of infection than HCWs in other
wards (7.3% vs 3.5%, p b 0.001). For bacterial co-infection, nurses had
a signiﬁcantly higher risk than doctors (3.2% vs 1.4%, p = 0.02) and
the rate was also signiﬁcantly higher in respiratory wards (4.4% vs
1.8%, p = 0.001). Respiratory wards had a higher rate of bacteria–
virus co-infection than other wards (2.5% vs 1%, p = 0.02).
Discussion
Wehave previously shown that N95 respirators protect against clin-
ical respiratory illness (MacIntyre et al., 2011, 2013). N95 respirators,
but not medical masks, were signiﬁcantly protective against bacterial
colonization, co-colonization, viral-bacterial co-infection and dual
virus infection in HCWs. We also showed a statistically signiﬁcant de-
crease in rates of bacterial respiratory colonization with increasing
levels of respiratory protection. The lowest rates were in the N95Table 1
Intention to treat analysis of bacterial, viral and bacterial–viral co-infections. Bold indicates “sig
N95 (n = 949) Medical (n =
All infections Efﬁcacy of N95 vs medical masks
% (95% CI)a
Bacteria 2.8% (27/949) 46.2 (8.8–68.2)
p = 0.02
5.3% (26/492)
Virus 1.4% (13/949) 48.2 (0.0–75.8)
p = 0.085
2.6% (13/492)
Bacteria or virus 3.3% (31/949) 49.8 (18.7–69.0)
p = 0.004
6.3% (32/492)
Co-infections
≥2 bacteria 1.7% (16/949) 48.2 (0.0–74.4)
p = 0.064
3.1% (15/492)
Virus and bacteria 1.0% (9/949) 33.3 (0.0–75.0)
p = 0.415
1.4% (7/492)
Co-infection
≥2 viruses 0.1% (2/949) 72.3 (0.0–96.0)
p = 0.05d
1.0% (5/492)
a Efﬁcacy and p-values were calculated using medical group as the referent category.
b Efﬁcacy and p-values were calculated using control group as the referent category.
c Efﬁcacy could not be calculated because zero events in the control group.
d Fisher's exact test was used to calculate the p-value because of small expected cell frequengroup, followed by the medical mask group, and the highest rates
were in HCWs who did not wear a mask. Although the clinical signiﬁ-
cance of this ﬁnding is unknown in terms of the implications for
HCWs, we have shown that such colonization can be prevented by the
use of N95 respirators. These ﬁndings are consistent with other work
we have published, which shows a reduction in bacterial colonization
following use of N95 respirators (MacIntyre et al., 2013).
While the role of nosocomial viral respiratory infections is accepted,
bacterial infections are less well understood. Our ﬁndings suggest that
bacterial respiratory tract colonization or infection in HCWs should be
studied further. Bacterial colonization may be a precursor to viral and
bacterial co-infections and invasive bacterial infections in individuals
with inﬂuenza or other respiratory viral infections. It is possible that
the onset of upper respiratory tract bacterial colonization may itself
cause mild respiratory tract symptoms, given that only symptomatic
HCWs were swabbed in our study. This requires further investigation,
in particular comparisonwith an asymptomaticHCWgroup.We believe
that these results may have occupational health implications for HCWs,
given the body of evidence that supports a complex, synergistic and
poorly understood pathogenic relationship between bacterial and viral
respiratory infection (Klugman et al., 2009; Madhi and Klugman,
2004; MMWR, 2009; Zhou et al., 2012). The ﬁnding that bacterial colo-
nization and co-infectionswere a greater risk on respiratorywards thanniﬁcant p value”.
492) Control (n = 481)
Efﬁcacy of N95 vs control
% (95% CI)b
Efﬁcacy of medical mask vs control
% (95% CI)b
62.0 (38.0–77.0)
p = 0.001
7.5% (36/481) 29.0 (0.0–57.0)
p = 0.16
56.1 (8.4–78.9)
p = 0.024
3.1% (15/481) 15.3 (0.0–59.2)
p = 0.657
59.7 (36.3–74.5)
p b 0.001
8.1% (39/481) 19.8 (0.0–48.9)
p = 0.336
57.8 (16.9–78.5)
p = 0.010
3.7% (18/481) 18.5 (0.0–58.5)
p = 0.550
62.0 (10.4–83.9)
p = 0.022
2.5% (12/481) 43.0 (0.0–77.4)
p = 0.227
Incalculablec
p = 0.553d
0.0% (0/481) Incalculablec
p = 0.062d
cies.
Table 3
Multivariable cluster adjusted log binomialmodel of any co-infections compared
with control group.
Variables in the model Relative risk (95% CI)
N95 0.41 (0.23–0.75)a,†
Medical mask 0.87 (0.44–1.73)
Hospital level 1.41 (0.77–2.56)
High-risk procedure 1.45 (0.84–2.50)
Inﬂuenza vaccine 0.90 (0.46–1.78)
Hand washing 1.07 (0.51–1.23)
a Efﬁcacy 59%.
† Signiﬁcant p values (p b 0.01).
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sion is occurring in HCWs. Interestingly, smoking was not a risk factor
for colonization or co-infection. We also found that nurses had signiﬁ-
cantly higher rate of bacterial co-infection than doctors. This may be
due to higher patient contact or differences in use of infection control
measures and personal protection (Chan, 2010; Chan et al., 2002).
The clinical signiﬁcance of bacterial colonization in HCWs is uncer-
tain, and this is an under-studied and unrecognized risk in HCWs. The
signiﬁcant protection against this afforded by N95 respirators mirrors
the same trend seen in our previous study for clinical outcomes
(MacIntyre et al., 2011, 2013). Outbreaks of bacterial respiratory
infection do occur in HCWs (Kleemola and Jokinen, 1992; Ong
et al., 2006; Pascual et al., 2006). Therefore, the observed reduction
in bacterial colonization may translate to clinical protection against
infection. S. pneumoniae was the most common bacteria identiﬁed
in the upper respiratory tract. Invasive pneumococcal disease is
thought to occur shortly after acquisition of colonization
(Boulnois, 1992; Gray et al., 1980), and the infection can be trans-
mitted by a colonized, asymptomatic individual. The rate of pneu-
mococcal colonization demonstrated in our study was 6% (30/481
in controls), which is within the range described in adults (who
have lower rates of colonization than children) (Austrian, 1986;
Kadioglu et al., 2008; Obaro et al., 1996; Ridda et al., 2011). In an
earlier study of frail elderly adults, only 1/315 subjects carried
S. pneumonia (Ridda et al., 2011), although rates of adult carriage
in the pre-vaccine era of up to 28% have been described (Hammitt
et al., 2006). Bacterial load in the nasopharynx, not measured in
this study, may be important in predicting the risk of invasive dis-
ease or viral co-infection and warrants further study (Klugman
et al., 2009). We demonstrated that N95 respirators prevent car-
riage with S. pneumoniae. Although S. pneumoniae is not typically
associated with outbreaks, nosocomial transmission and invasive
disease in hospital patients from a carrier HCW have been reported
(Guillet et al., 2012). In addition, transmission of bacterial patho-
gens from patients to HCWs during high-risk procedures has been
described (Baba et al., 2009).Table 4
Multivariable cluster adjusted log binomial model of bacterial and viral co-infection
compared with control group.
Variables in the model Relative risk (95% CI)
N95 0.33 (0.14–0.78)a,†
Medical mask 0.59 (0.20–1.73)
Hospital level 1.93 (0.80–4.62)
High-risk procedure 1.22 (0.52–2.86)
Inﬂuenza vaccine 1.60 (0.64–4.01)
Hand washing 1.24 (0.37–4.11)
Respiratory ward vs other 2.85 (1.30–6.26)†
a Efﬁcacy 67%.
† Signiﬁcant p values (p = 0.01).The issue of co-infection is not well studied in HCWs, therefore our
ﬁndings are quite novel. We have shown that all combinations of co-
infection or co-colonization, with bacteria, viruses and both bacteria
and virus, occur in symptomatic HCWs. These co-infections also display
the same trend of decreasing frequencywith increasing respiratory pro-
tection.Whatever their clinical signiﬁcance, co-infection can be reduced
by respiratory protection, and this may have implications for both pa-
tient safety, control of outbreaks and occupational health and safety of
HCWs in hospitals. Co-infections, particularly bacterial–viral co-
infection and dual viral infections can be more clearly implicated in
causing disease in HCWs than colonization with a single bacterial spe-
cies. This aspect of our ﬁndings, as well as the increased risk for staff
in respiratory wards, therefore, has more direct clinical implications.
We demonstrated 59% efﬁcacy against control of N95 respirators
against any co-infection, and 67% against bacterial/viral co-infection.
Medical masks were not protective and may in fact increase the risk of
viral co-infections (5/492 compared to 0/481 in controls and 2/949 in
N95). This ﬁnding, while not reaching statistical signiﬁcance, may be
due to chance, but is concerning and should certainly be investigated
further. It is possible that the physical conditions of a medical mask
may increase moisture or other parameters to increase risk of co-
infection.
The limitations of this study include the fact that we did not test
asymptomatic subjects, and therefore cannot examine the relationship
of bacterial colonization to symptoms. Quantitative data on bacterial
load would also have strengthened the study. Finally, the mechanisms
of protection of a mask against respiratory tract colonization may be
multi-modal. A mask may protect against respiratory transmission of
pathogens, but may also act as a barrier to reduce hand to nose or
hand to face contact, and may reduce infection in this way. Barrier pre-
cautions have been shown to reduce the rate of nasopharyngeal bacte-
rial colonization (Safdar et al., 2006), so it would be expected that the
barrier provided by a mask may have the same effect. A limitation of
this study is that we cannot differentiate the relative contributions of
prevention of airborne, droplet or direct contact transmission, but the
study provided clinical efﬁcacy estimates regardless of the different
potentialmechanisms of protection. If masks act by preventingmultiple
modes of transmission, they could have utility in preventingmultidrug-
resistant bacteria colonization of the nasopharynx of HCWs. Organisms
such as methicillin-resistant S. aureus (MRSA) are a serious hospital in-
fection control problem for HCWs (Morgan et al., 2012). Rates of clinical
infections in HCWs with MRSA of 5.1% have been described, as has
transmission of MRSA from HCWs to patients (Elie-Turenne et al.,
2010; Sherertz et al., 2001; Verwer et al., 2012;Wang et al., 2011). A fu-
ture research question could be the role of masks in preventing MRSA
colonization in HCWs.
In summary, we have described novel data on bacterial infection
and co-infections in HCWs, something which has not widely been
documented or accepted previously, and shown that N95 respirators
consistently provide protection against bacterial colonization and
co-infections of the respiratory tract of hospital HCWs. The risk of
such colonization is higher in ward types where more respiratory in-
fections are expected (such as respiratory wards). The documented
nosocomial outbreaks of bacterial infections such as pertussis and
even S. pneumoniae in HCWs (Guillet et al., 2012; Pascual et al.,
2006), as well as the efﬁcacy against co-infections suggest there
may be occupational safety beneﬁts to HCWs in high-risk settings
using a respirator, and that more studies are needed to better under-
stand potential bacterial nosocomial respiratory pathogens.
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